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ABSTRACT
Background: Systemic lupus erythematosus (SLE) is a lifelong multisystem autoimmune
disorder characterized by the presence of autoantibodies that are directed against nuclear
antigens. The disease is the most common type of lupus that has a heterogeneous presentation,
and an affinity for the female gender with a peak onset in normative childbearing years. It
becomes important for anesthesia providers to understand the potential complications that they
may encounter during the obstetric management of this population, during cesarean sections.
Recommendations that address the disease’s heterogeneous presentation and effect on the
parturient organ systems provides a template for anesthesia providers during the perioperative
management of the obstetric SLE patient.
Objectives: This quality improvement (QI) project aims to improve healthcare provider
knowledge regarding the clinical implications of SLE, during the obstetric management for a
cesarean section, to reduce morbidity and mortality for mother and newborn.
Setting: Setting: A 716-bed acute care hospital in Broward County, Florida, which has a large
obstetric population requiring anesthetic services. Anesthesia providers at this facility will be
educated on the maternal- foetal dyad that can present during the management of the SLE mother
during cesarian section.
Methods: A pretest survey will be administered to assess anesthesia providers’ knowledge,
attitudes, and behaviors regarding the management of the SLE parturient during cesarian section.
An educational module will then be provided. Finally, a posttest survey containing the same
questions as the pretest will be administered to participants.
Results: Following the educational intervention, there was an increase in knowledge scores and
stronger attitudes and beliefs regarding the role of anesthesia providers in the management of the
SLE parturient during a cesarean section. Furthermore, most participants reported that they were
highly likely to implement this into their clinical practice.
Conclusions: The empirical evidence shows that parturients with SLE present with a higher
incidence of systemic complications that increases the risk of poorer outcome for both the mother
and baby. Anesthesia providers must have a thorough understanding of the clinical implications
of SLE, during the obstetric management for a cesarean section, as this will reduce morbidity and
mortality for mother and newborn. An educational module can enhance anesthesia provider
knowledge and increase the likelihood of improved outcomes for mother and neonate, during the
anesthetic management of a SLE parturient during a cesarean section.

Keywords: Systemic Lupus Erythematosus, SLE, Lupus, Pregnancy, Cesarean Delivery,
Cesarean Section, Anesthesia, Obstetric Anesthesia
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INTRODUCTION
Description of the Problem
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disorder characterized
by the presence of autoantibodies that are directed against nuclear antigens. The disease has a
heterogeneous presentation, dominating in the female gender with a peak onset being between
ages 15 and 40; during normative childbearing years.1,2,3 Parturients with SLE face innumerable
challenges throughout pregnancy, as the disorder compromises the potential for the best maternal
and fetal–neonatal outcome. Women presenting with the condition are at risk for systemic issues
from lupus flares; these include deteriorating renal impairment, inception or worsening
hypertension, pre-eclampsia, and venous thromboembolism. 1,2,3 The presence of SLE in
parturients leads to complications that may result in adverse fetal and parturient outcome, making
it necessary for providers to have an optimized perioperative anesthetic plan in place.
It is estimated that a little over 200,000 Americans experience SLE. 4 In recent studies, an
actual account of the extent of the illness reviewed available data from several state registries to
track the illness, that was created over a decade ago, by the U.S Centers for disease Control and
Prevention (CDC). 4 The study concluded that for every 100,000 people, 72.8 have SLE. 4 The
research additionally identified that women were nine times more likely to have SLE with it
disproportionately affecting women of Black, American Indian/Alaskan Native and Hispanic
descent. 4 The condition comes statistically close to being considered a rare disease, as defined by
the U.S Rare Diseases Act of 2002, which identifies conditions that affect 200,000 or fewer
Americans. 4 Researchers previously relied on the estimates of patients with SLE, which were
largely over estimated and unverified. Researchers have determined that acknowledging that
SLE’s statistical closeness to being considered a rare illness decreases the number of study
participants needed for testing, new treatments, and clinical trials for the disease.
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Women with lupus were once advised by providers that pregnancy should be avoided due
to the potential risks to mother and baby. Novelty research has led to knowledge about the nature
of the disease and new approaches to treat and manage the condition. Additionally, research has
shown that understanding the specific factors that increase the risk during SLE pregnancies can
lead to successful outcome for the parturient and the baby. A provider’s understanding of
important factors that have been shown to increase the risk of complications for the parturient and
baby include severe organ damage related to prior disease, active or uncontrolled SLE and the
time of delivery and the presence of autoantibodies. Even with improvements in the management
of the SLE parturient, women with lupus are more likely to experience pregnancy related
complications, when compared to women without the disease. Complications experienced by the
SLE parturient, at the time of delivery, may include premature delivery, low- birth weight babies
and unmanageable lupus flare ups that may cause organ damage to the parturient. Pregnant
women with lupus also have a much higher risk of experiencing complications such as
preeclampsia, and eclampsia, when compared to the general parturient population.

Parturients with SLE require anesthesia that is tailored to their individual need, and
successful anesthetic management requires optimized practice guidelines for patients who present
for elective or emergent cesarean sections. This research synthesizes various study designs
published in the last 20 years, with a focus on recommendations based on current scientific
management for the parturient. The compilation of current research serves to review the
systematic effects of lupus and present best practices that will optimize the perioperative
anesthetic management of this population, during cesarean section.
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Background
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that primarily
affects women during their reproductive years.1,2,3 To date, there are no general treatments for
SLE because of the heterogeneity of the disorder characterized by periods of remission and
exacerbation. The expected onset usually occurs during the second to fourth decades of life
which places women at increased risks for exacerbation during pregnancy.2,3,4 The management
of SLE during pregnancy is challenging for providers, and the unfortunate outcome for
parturients with this condition include pre-eclampsia, eclampsia, preterm delivery, spontaneous
abortions, intrauterine growth retardation, and intrauterine foetal death.1,2,3 Parturients presenting
with SLE are faced with the added task of having their babies via cesarean section, emergently or
electively, as the complications faced by these parturients lessons the probability of natural or
vaginal births.2,4
Historically, the occurrence of preterm birth and cesarean deliveries occur more
frequently in patients with SLE when compared to the general population.1,2,3,4,5 Comparatively,
parturients with cutaneous lupus erythematosus (CLE) and rheumatoid arthritis (RA) are less
likely to present with lower rates of disease exacerbation when compared to parturients with SLE.
5, 12

Additionally, parturients with SLE are reported to have a higher rate of medically indicated

deliveries, when compared to CLE and RA mothers, at the time of labor. 12 Much of the
implications in the pathogenesis of SLE are genetic, as the rate of lupus is 24%-60% in
monozygotic twins and 2%-5% among dizygotic twins.10
In the United States, the occurrence of cesarean deliveries has dramatically increased
over the past 30 years.6 Retrospective studies show that parturients with SLE experience more
pregnancy complications.2 While it has been documented that preterm deliveries and cesarean
sections occur more frequently in parturients with SLE, studies are limited as to whether these
preterm deliveries are spontaneous or medically indicated.5 The anesthetic management during
cesarean section of a parturient with SLE can be successful; if appropriate measures are
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implemented. Moreover, inappropriate anesthetic care can cause mismanagement of SLE
parturients, which leads to poor outcomes such as fetal loss, preterm birth.1
The successful perioperative management of the SLE parturient, during a cesarean
section relies heavily on an anesthetic plan that is tailored for the individualized needs of the
patient. 4,5.7 Anesthetic choice technique and patient management relies on the discretion of the
provider and their decision that should consider the severity of the disease, drug interactions with
immunosuppressants, and unexpected difficult airway, coagulopathy, and systemic organ function
for the parturient. SLE systems overlap with the physiological changes of pregnancy and as a
result, may present as nonspecific. 1-4
Cardiovascular involvement in the SLE parturient can include pericarditis, myocarditis,
arthrosclerosis, and myocardial ischemia. Noninfectious vegetation, known as Libman- Sachs is
one of the ways in which valvular anomalies may present in this pertinent. 6.7 Additional cardiac
variance may include rhythm and conduction anomalies and atrioventricular blocks.
Complications involving hypertension can affect up to 20% of parturients with SLE which may
be brought on by pregnancy and can increase the risk of preeclampsia.7 Approximately one in
every 5 lupus pregnancies experience preeclampsia, which may unfortunately require immediate
treatment and often the cesarean delivery of the baby. 7,8
Airway and pulmonary involvement can range from the unexpected difficult airway with
subglottic stenosis and laryngeal edema to the presence of pleuritis, pleural effusion, alveolar
hemorrhage, and interstitial disease. 8 Pulmonary hypertension, pulmonary parenchymal and
vascular inflammation can present secondary to SLE, in the parturient with SLE. The parturient
can present with arthritis, due to the prolonged use glucocorticoids for immunosuppression that
can lead to osteoporosis; contributing to the increased incidence of reported atlantoaxial
subluxation.6,7
Proteinuria, hematuria and abnormal urinary segments can be seen in a urine analysis for
the pregnant patient with lupus and irrespective of their pre-pregnancy renal status, the parturients
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with SLE are at a higher risk of developing pregnancy induced hypertension (PIH).8,10 This risk
increases even more in SLE parturients requiring greater that 30mg of prednisolone for daily
disease management.10 Lupus nephritis is the primary presentation of renal complications in the
parturient presenting with SLE. Approximately 37-39% of parturients with lupus manifest
peripheral nervous system complications; with symptoms that range from headaches, seizures,
cardiovascular disease, psychosis, acute confusion to demyelinating disease states.8,9
Anemia in the SLE combined with the dilutional anemia of pregnancy worsens the
hematologic state of the parturient. Hematologic conditions commonly seen in parturients with
SLE include anemia, thrombocytopenia and leukopenia; with anemia of chronic disease is present
in half of the patient population.8,10 Other causes of anemia in the SLE parturient include:
autoimmune hemolytic anemia, iron deficiency anemia, anemia of chronic renal failure, and
cyclophosphamide myelotoxicity.8,10 The diverse array of autoantibody production, immune
complex deposition, and tissue organ damage are a few other defining characteristics of SLE. 10,28
Studies conducted show that the coagulation cascade and complement system had an interaction
effect on SLE disease severity, this effect was pronounced among patients with excess
inflammation.10,28
Conditions that may occur secondary to SLE include antiphospholipid syndrome which is
clinically characterized by the recurrence of miscarriages and the presence of lupus antibodies
that can prolong the partial thromboplastin time. 6,7,10,28 The SLE Parturient with a pregnancy
complicated by antiphospholipid syndrome necessitates the use of heparin and aspirin to prevent
thrombosis. 6,7,10
The preferred method of anesthesia, for the SLE parturient presenting for a cesarean
section is regional anesthesia. As with all cesarean sections, the anesthesia provider should
anticipate and prepare for a difficult airway, which may range from mild inflammation to
laryngeal edema, epiglottis, vocal cord paralysis to an acute airway obstruction. 6 An anesthesia
provider must have available: smaller sized tube, and laryngeal mask airway in preparation for a
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potential laryngeal or subglottic involvement. Unfortunately, the pathophysiology of laryngeal
inflammation of SLE is not entirely understood, however, it is believed that tissue deposition of
immune complexes with activation of complements is probably the cause. 6,7 Other airway
complications include left palsy, in the SLE parturient which is due to the compression of the
recurrent laryngeal nerve by the pulmonary artery.6 Parturient with lupus who require a cesarean
section may also have additional extracellular fluid resulting in additional engorgement,
significantly increasing the risk of airway trauma during instrumentation or failed intubation. 6
The primary goal for the successful perioperative management of parturient with SLE
during a cesarean section, is to provide care that prevents serious adverse sequelae. The
multisystem disorder requires a thorough preanesthetic evaluation and an individualized plan
based on the parturients system involvement, current medications regimen and laboratory
findings. Additionally, providers must have a thorough understanding of the disorder and its
effects on a parturient during a cesarean obstetric anesthetic management.
Systematic Review Rationale
The American College of Rheumatology (ACR) has provided standardized guidelines for
the diagnosis and management of SLE, with the original recommendations, published in 1982
updated in 1997.9 Additionally, there are international clinical practice guidelines (CPG) for the
treatment of SLE, however, there are limited practice guidelines for obstetric anesthetic
management during cesarean section. In this paper, the reader will find a presentation of the
clinical features exhibited by SLE parturients and recommended guidelines for the anesthetic
management of a patient with SLE during a cesarean section.
Systemic Lupus Erythematosus has several disease manifestations that may be exhibited
in the parturient during cesarean delivery. Some of the more common indicators include arthritis,
hematological disorders, neuropsychiatric disorders, nephritis, pleuritis, pericarditis, and
photosensitivity. Patients with SLE can present with myocardial injury that is attributed to
accelerated atherosclerosis, myocardial inflammation, and disease that are microvascular in
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nature (14). In this population, the use of troponin I (cTnI) and troponin T (cTnT) are the cardiac
biomarkers of choice for patients presenting with chest pain.14,15 In a double-blinded study
performed between 2007 and 2010, 473 patients were analyzed, and highly sensitive assay cTnT
measured in serum was the first identified biomarker independently associated with incident CVE
in SLE patients.14 Myocardial involvement, in the presence of SLE requires clinical attention in
parturients, as this can lead to cardiac arrhythmias, heart failure, and cardiogenic shock.14,15
Pericarditis is a common cardiac manifestation and is recognized by the ACR as a
diagnostic criterion for SLE. Incidence of pericarditis widely ranges in the literature, from 1154%, with one-third of these patients develop symptomatic pericardial involvement (14, 15,16).
The usual occurrence of pericarditis is at the onset of the disease and during flare-ups, when the
patient faces physiological stressors, such as pregnancy. 14, 15 Standard management would
include Nonsteroidal anti-inflammatory drugs (NSAIDS) and corticosteroids; more extensive
management of a cardiac tamponade would include pericardiocentesis or a pericardial window.
Myocarditis is another characteristic of SLE and is seen in up to 10% of patients experiencing this
disease. 14 SLE myocarditis can progress to arrhythmias, heart failure, dilated cardiomyopathy,
ventricular dysfunction, and dilated cardiomyopathy, although other factors may be responsible
such as hypertension, accelerated atherosclerosis with ischemia, valvular disease, renal failure,
and treatment toxicity from cyclophosphamide or hydroxychloroquine.14,15
PICO Question
The PICO format was utilized to frame the clinical question, which guided the search
criteria. From the research presented on SLE, the following PICO question was formulated: For
parturients with systemic lupus erythematosus (SLE), does current practice, when compared to
non- SLE parturients, reduce perioperative anesthetic complications during cesarean section?
METHODOLOGY
Information Sources and Search Strategy
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The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
checklist was used as the focused guide used to locate systematic reviews and meta-analyses for
randomized studies.12 A thorough search was conducted on several electronic databases,
including Cumulative Index to Nursing and Allied Health Literature (CINAHL), MedLine
(ProQuest) and Excerpta Medica Database (EMBASE). The search results were restricted to
articles that were published in English from the year 2000 to 2020 to establish any gaps within
the literature. The initial search criterion was inclusive of articles published between 2010 to
2020; this, however, limited the availability of studies inclusive of parturients with SLE. Table 1.
Provides a detailed list of the exact terms, subject terms, headings, and filters applied in each
database search. The identified problem and PICO question guided the literature search. The
comprehensive literature search helped retrieve 9 articles that were synthesized into two themes.
The themes included pregnancies complicated by SLE and parturient need for cesarean section
Figure 1, is a PRISMA flow diagram used to provide a visual representation of this systematic
review and the screening processes used in this systematic review.16

Table 1. Database Search Table
Concepts/
Topics

CINAHL

Systemic Lupus
Erythematosus
or SLE or
Lupus

Pregnancy,
Pregnant or
Parturient

Anesthesia

(MH "Systemic
Lupus
Erythematosus")
OR (MH
"SLE") OR
(MH "Lupus")

(MH
"Pregnant")
OR (MH
"Pregnancy")
OR
Parturient*

(MH
"Anesthesia
") OR (MH
"Anesthesia,
Obstetrical")
OR
anesthes*
OR

OR pregnan*

or
Obstetrics
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Cesarean Filters
Section
Applied
or
Delivery
or Labor
(MH
"Cesarean
Section")
OR (MH
"Cesarean
Delivery")
OR C

•

Peer
reviewed
filter
applied
and 78
results
found

MEDLINE
(Proquest)

MESH.EXACT
("
Systemic
Lupus
Erythematosus"
)
OR
MESH.EXACT
("Lupus") OR
MESH.exact("
Management--SLE") OR
MESH.EXACT
("SLE") OR
systemic lupus
OR Lupus

MESH.exact("
Pregnant")
OR
MESH.exact
("Parturient")
OR
MESH.exact("
Pregancy")
OR pregnan*
OR
parturient*

anaesthes*
OR
Obstetric*
OR regional

Section*
OR

MESH.exact
("Anesthesia
") OR
MESH.exact
("Obstretric,
Anestheia - adverse
effects") OR
MESH.exact
("Anesthia*
") OR
anaesthes*
OR regional

MESH.E •
XACT("C•
esarean
Section")
OR
MESH.E
XACT("L
abor") OR
Cesarean*
OR
cesarean
deliver*
OR c
section

OR “Lupus*”
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labor*
998 results
Applied peer
reviewed,
female filter,
English Filter,
2000-2020,
Human Filter,
and Journal
Article type to
get 122
results

EMBASE

' Systemic
Lupus
Erythematosus
OR 'Lupus”
OR 'SLE OR
Systemic
Lupus
OR
System* Lupus

'pregnant'/exp
OR
‘Pregnancy’
/exp OR
'Parturient'/ex
p OR
pregnant
parturient

'anesthesia'/
exp OR
‘Obstretics
/exp OR
'obstetric
anesthesia'/e
xp OR OB
OR regional
anesthes*
OR
anaesthes*

OR
“SLE*” OR
“Lupus*”
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'obstetric •
delivery'/e
xp OR
'gynecolo
gic
surgery'/e
xp OR
Obstetric*
OR
parturient
* OR
labor OR
gynecolog
ic* OR
pregnant

112 results
Found
Filters
applied:
Female,
Article
publicatio
n type,
drugs
ondansetro
n, and
dates
20002020. 31
results
then found
• EMBASE
ONLY
(removed
Medline
duplicates)
and came
out to 17
results

Figure 1. PRISMA Flow Diagram

Records identified through
Cumulative Index to Nursing and
Allied Health Literature (CINAHL),
MedLine (ProQuest) and Excerpta
Medica Database (EMBASE)
(n= 3408)

(n =for
217)
Records excluded
not having substantial
support for the proposed research
(n=3111)

Duplicates
(n=150)

(n = 80)

Full- text articles assessed
for eligibility
(n=123)

Full-text articles excluded, with reasons
(n = 16)
Non-SLE parturients (3)
Parturients with SLE, with terminated
pregnancies (2)
Systematic reviews of literature (5)
Outcome not appropriately reported (6)

Studies included in
qualitative synthesis
(n =8)
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Study Selection and Screening Method with Inclusion/Exclusion Criteria
The investigators screened titles and abstracts specific to the preliminary PICO question.
The investigator reviewed the data collection and analysis to make the appraisal more reliable and
to prevent bias. Selected articles were organized using “EndNote Library” into a “relevant” and
“irrelevant” folder. A total of 123 articles were placed in the “irrelevant” folder and 8 articles into
the “relevant” folder.
The investigators completed a full- text assessment on all 8 relevant articles based on the
following inclusion criteria: articles published in the English language, articles published between
2000 to present, double-blinded RCTs, Systemic Lupus Erythematosus or SLE or Lupus,
Pregnancy or Obstetrics, Cesarean Delivery or Cesarean Section and Anesthesia. Results that did
not include the previously mentioned search terms were excluded from this systemic review.
Table 2 outlines the exclusion criteria and inclusion criteria used for this systematic review. The
studies that did not include the parturient population or address patient management during
cesarean sections were also scrutinized, some were selected and used for this systematic review
due to the lack of research specific the SLE parturient. Additionally, limitations in the availability
of double- blinded RCTs, resulted in the expansion of the inclusion criteria to also include
retrospective cohort studies, population based- national studies and case studies.
Table 2. Inclusion and Exclusion Criteria
Inclusion

Exclusion

Population:

Population:

•
•
•

•
•
•

Female
Women
Obstetric (OB)

Male
Non-OB
Children (<18 years old)

Type of procedure:

Type of procedure:

• Anesthesia for cesarean delivery
• Management during cesarean delivery
Intervention:

•
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Anything other the management
of parturients for cesarean
delivery (e.g., laparoscopy,
cardiac or cystoscopy procedure
for SLE population)

•

Studies that include various considerations for the
management of parturients with SLE during cesarean
sections

Primary outcomes:
•

•

•

Selective maternal outcomes- included cesarean
section, pre-eclampsia, hypertension, postpartum
hemorrhage, perioperative or post-operative blood
transfusion, thromboembolic disease, post-operative
maternal fever
Selective fetal outcomes- included spontaneous
abortions, premature births, stillbirths, fetal death,
low birth weight, one-minute Apgar scores less than
7
Anesthetic implications for SLE parturient during
cesarean obstetric management- regional anesthesia

Type of study:
• English language
• Randomized controlled trials
• Publication date 2007-Present
• Retrospective Analysis
• Cohort Studies
• National Studies

Intervention:
•

Obstetric management of
patients who do not have SLE
• Patients with SLE who are not
undergoing cesarean sections
• Parturient complications for
patients who do not have SLE
Primary Outcomes:
•

Anything unrelated to cesarean
obstetric management of an SLE
parturient

•
Type of study:
•
•
•
•
•
•

Non-English
Publication date pre-2000
Duplicates of the same study
Systematic reviews
Questionnaire
Dissertations/theses

Collection, Analysis and Data Items
Using an appraisal checklist, studies were evaluated and selected for this systematic
review. 17 A Critical Appraisal Skills Programme’s Checklists (CASP) provided the structural
framework which allowed the investigator to appraise the cohort studies and case control studies
that we selected.17 The rating scheme for research evidence, outlined by the CASP checklist uses
11 questions to help in understanding randomized controlled trials. Items taken into consideration
by the CASP assesses the validity of the trial, the soundness of the study method, assessment of
the results questions the value of the experiment to the persons in the investigator’s selected
target population. 17
A nationwide population-based study was also used in this systemic review. The 11
question CASP Checklist for Case Control Study addressed three broad issues which assessed the
actual results, questioned the validity of the results and the importance of the finding to the
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investigator’s population. The use of the CASP Case Control Study Checklist and the CASP
Cohort Study Checklist were also used to evaluate the literature presented in the case studies and
retrospective studies that were also included in the systematic review. 17
Upon the completion of each evaluation, a level of quality was assigned to each study,
based on the critical appraisals performed by the investigator on each CASP checklists used for
literature evaluation. Table 3 presents the strengths and weakness of each study as well as the
information obtained and evaluated from each study. The content provided in the table includes:
the study design and method, study sample or setting, major variables studies and defined,
measurement and data analysis, study findings, results, and study conclusion. The evaluation
table also cites the author and year of publication.
RESULTS
Study Selection
Three thousand four hundred and eight articles were obtained after performing and
electronic search of Cumulative Index to Nursing and Allied Health Literature (CINAHL),
MedLine (ProQuest) and Excerpta Medica Database (EMBASE). Following careful review of
titles, abstracts, 3,111 articles were eliminated for not having substantial support for the proposed
research. An additional 150 duplicates were removed and a total of 123 full-text articles were
assessed for suitability. Further elimination, based on the strict inclusion and exclusion criteria
included articles that did not include parturients with SLE (3), studies that included parturients
with SLE who terminated the pregnancy (2), systematic reviews of literature (5) and outcomes
that were not appropriately reported (6). Unfortunately, search results did not identity RCTs that
included the anesthetic management of the SLE parturient during a cesarean section that met this
systematic review. Two Case- Control Studies addressed the use of regional anesthesia during the
management of the SLE parturient. Ultimately, the study selection resulted in 6 retrospective
cohort studies, 1 population based- national study and 2 case-controlled studies that were
included in this systematic qualitative review that answered the PICO question: “For parturients
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with systemic lupus erythematosus (SLE), does current practice, when compared to non- SLE
parturients, reduce perioperative anesthetic complications during cesarean section?” According to
the John’s Hopkin’s appraisal scale, cohort studies allow investigators to draw conclusions
regarding the link between risk factors and disease.19 The goal of this review is to use these
studies to enhance the anesthesia provider’s understanding of the potential complications
associated with the care of the SLE parturient, during a cesarean section. Table 3 provides a
summary of all studies included in the systematic review.

Table 3. Studies Included in the Appraisal
Author (Year)
& Type of
Study

Study Method, Participants,
Interventions, & Setting

Findings

Abdwani et al.
(2018)

Maternal and neonatal outcomes
of pregnancies in SLE patients.

Abortions (42.8% vs. 15.3%; p <
0.001),
Gestational diabetes (28.3% vs. 10.2%;
p = 0.004).
Polyhydramnios (7.1% vs. 0.0%; p =
0.020),
Previous preterm pregnancies (8.9%
vs. 1.0%; p = 0.030),
Intrauterine growth retardation (21.4%
vs. 0.0%; p < 0.001).

Pregnancies in health controls
were used as the comparison.
Retrospective
Cohort Study

The study was conducted in a
tertiary hospital in Oman
147 pregnancies
56 (38%) parturients with SLE
were involved in the study.
91(61.9%) parturients without
SLE

Eudy et al.
(2018)

Retrospective
Cohort Study

Parturients with SLE and RA
prospectively followed until childbirth to assess type of birth and
gestational age of infant at time of
birth.
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S LE pregnancies had modestly higher
rates of preterm birth (24% SLE vs
14% RA),
pre-eclampsia (15% SLE vs 7% RA)
cesarean delivery (48% SLE vs 30%
RA)
Majority of preterm births among
women with SLE were indicated

The study was conducted in a
tertiary hospital in the United
States

(70%), commonly for pre-eclampsia or
the health of the infant or mother.

126 total pregnancies
82 parturients with SLE were
involved in the study.
44 parturients with RA
Clowse et al.
(2005)

Retrospective
Cohort Study

Lui et al. (2012)

Retrospective
Cohort Study

229 (85.8%) resulted in a live birth.
High-activity lupus occurred in 57
pregnancies (21%).
Fewer pregnancies among women with
high activity lupus ended with live
births (77% versus 88% of those with
low-activity lupus; P= 0.063).
Study was conducted in the United Full-term delivery was achieved in 15
pregnancies (26%) among women with
States.
high-activity lupus.
267 pregnancies in 203 parturients 127 pregnancies (61%) achieving fullterm in those with no or mild lupus
with SLE were evaluated in this
activity (P < 0.001).
study.
High-activity lupus in the first and
second trimesters led to a 3-fold
increase in pregnancy loss
(miscarriages and perinatal mortality).
Frequency of abnormal pregnancy There were 23, 2, and 5 elective,
spontaneous, and still births,
outcomes, Identifiable laboratory
respectively.
findings and clinical factors that
Live births were reported in 81 of the
could predict adverse maternal and
pregnancies out of which 17% were in
fetal outcomes among women
the patients with SLE.
diagnosed with SLE
Preeclampsia/eclampsia (OR ¼ 14.83,
95% CI: 3.83–57.41) and
The study was conducted in China. thrombocytopenia (OR ¼ 4.43, 95%
CI: 1.12–17.60) were predictors of
111 Parturients
fetal loss; preeclampsia/eclampsia (OR
¼ 8.04, 95% CI: 2.00–32.34).
105 parturients with SLE were
Preterm birth; preeclampsia/eclampsia
involved in the study.
(OR ¼ 8.92, 95% CI: 2.25–35.44)
were significantly associated with
active SLE (OR ¼ 19.90, 95% CI:
2.38–166.27). Thrombocytopenia (OR
¼ 4.03, 95% CI: 1.24–17.25) were
significant predictors of maternal SLE
flare-up.
Assess all pregnancies in a cohort
of lupus patients who were
observed prospectively from 1987
to 2002.
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Mehta, et al.
(2019)

Retrospective
Cohort Study

Assess nationwide trends and
disparities in maternal and fetal
complications among pregnant
women with SLE
Adult pregnant women with and
without SLE who had
hospitalizations recorded in the
National Inpatient Sample (NIS)
database between 1998- 2015

Outcomes improved during those 18
years.
In-hospital maternal deaths (per
100 000 admissions) declined among
patients with as well as those without
SLE (442 vs. 13 for 1998 to 2000 and
<50 vs. 10 for 2013 to 2015),
Decrease was greater in women
with SLE (difference in trends, P <
0.002).

Study occurred in United States.
93 820 parturients with SLE were
involved in the study

The percentage of patients with SLE in
all pregnancy-related, as well as
delivery-related, admissions increased
significantly.

78 045 054 parturients without
SLE
Vyas et al.
(2014)

Management of an antinuclear
antibody positive parturient who
spinal anesthesia was administered
during caesarian section

Case- Control
Study

No data analysis conducted
A report of the guidelines adhered
during the spinal anesthesia

Nili et al. (2013)

Retrospective
Cohort Study

Determine maternal and neonatal
outcomes in pregnancies
complicated by systemic lupus
erythematosus (SLE).
Study occurred in Canada.
97 parturients with SLE
211255 parturients without SLE
The study was conducted at an
intensive care unit and department
of anesthesiology of a healthcare
facility.
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It was identified that the patient had a
normal bleeding, clotting, and
activated partial thromboplastin time.
The baby cried immediately after
delivery, had a normal APGAR score,
and no signs of neonatal lupus were
identified.

SLE increased the risks of Caesarean
section (OR 1.8; 95% CI 1.1 to 2.8, P
= 0.005), postpartum hemorrhage (OR
2.4; 95% CI 1.3 to 4.3, P = 0.003),
need for blood transfusion (OR 6.9;
95% CI 2.7 to 17, P = 0.001),
postpartum fever (OR 3.2; 95% CI 1.7
to 6.1, P = 0.032), small for gestational
age babies (OR 1.7; 95% CI 1.005 to
2.9, P = 0.047), and gestational age ≤
37 weeks (OR 2.1; 95% CI 1.3 to 3.4,
P = 0.001).
Neonatal death was not shown to be
more common in women with SLE
(RR 3.05; CI 0.43 to 21.44, P = 0.28).

Kiran et al.
(2016)

Anesthetic management of a
parturient with who underwent
elective lower segment cesarean
section

Case- Control
Study

No measurement of data reported

patient’s recovery from general
anesthesia was not associated with any
complications. The patient’s vitals
were stable and no damage to the
organ systems such as the
neurological, musculoskeletal, cardiac,
renal, hematological, and respiratory
systems were identified.

Study Characteristics
The selected peer-reviewed literature used in this review had a combined total of over 20
million parturients, of which 107,983 parturients were diagnosed with SLE. All studies
referenced were published between 2000 to 2020, in the English language. The patient
demographic characteristics and intervention features were not significantly different across all 8
studies. All participants were female parturients who were potential candidate for cesarean
section. The participants included individuals diagnosed with and without SLE.
Patient demographics. The obstetric patients in the studies were identified as women,
from various ethnic backgrounds, with an age range of 18-50. 6,7,8,20, 23,24 In one study, it was
highlighted that some women in the cohort had several pregnancies during the study period, that
ranged from 1988 to 2008, because of the statistical significance of observed differences, the data
was assessed using a generalized estimating equations approach.21 The overall range of SLE
patient evaluation spanned from 1987- 2015. 6,7,8,20, 23,24 The gestational weeks for the participants
ranged from 37-42 weeks in 3 of the studies. 6,7,24 In study performed by Mehta et al. it was noted
that mothers with SLE were older than the non-SLE parturient.25 All the studies were explicit in
stating their inclusion and exclusion criteria. 6,7,8,20, 23,24
Hospital Demographics. Most of the studies took place at hospitals in the United States
(U.S.). One of the U.S. based cohorts was the Hopkins Lupus Cohort which only
included pregnancies that occurred during the woman's care in the Lupus Clinic are included in
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this analysis.6 Th retrospective cohort study conducted by Nili et al., took place in Canada; the
team obtained data from the Nova Scotia Atlee Perinatal database.20 The National Inpatient
Sample (NIS) was the database use for the study conducted by, Mehta et al; It provided
healthcare records from more than 1000 participating hospitals.24 Another was conducted at the
Sultan Qaboos University Hospital, a rheumatology referral center in Oman.8 The only Chinese
retrospective study used the data collected from January 1990 to December 2008 in Peking Union
Medical College Hospital in Beijing.1
Methodology. Studies that acknowledged original data collection for the studies included
physicians, specializing in pediatrics and rheumatology.6,7,8,20, 23,24 Additionally, one study also
included a pharmacist.21 Due to the retrospective focus of majority of the studies used for this
systematic review, data used were primarily obtained from registries. In one study, pregnant
women with SLE and RA were prospectively followed by a single rheumatologist in the Duke
Autoimmunity in Pregnancy (DAP) Registry from 2008 to 2016.7 Trained personnel, using
standardized forms collected the data for the Nova Scotia Atlee Perinatal database, in Canada. 20
Ninety- Five percent of the U.S. population is represented in the NIS, the system used to retrieve
data for the retrospective study performed by Mehta et al. 24
Variations were noted in the data collection practices in all the studies used in the
systematic review. In the 2005 study by Clowse et al., the study design was to assess all
pregnancies, with SLE, who were observed prospectively from 1987 to 2002.6 The parturients
lupus activity was estimated with the use of a visual analog scale (high‐activity lupus defined as a
score of ≥2). 6 The physician’s estimates for lupus activity (PEA) were based on the patient
medical history, examination findings and laboratory findings, with a scale range of 0 to 3. 6 The
disease activity in each trimester was compared and the investigators assessed the impact of high‐
activity lupus during pregnancy on gestational age, live birth rate, and small for gestational age
babies. 6 Potential comorbidities, including demographics of the women as well as maternal
history of lupus, renal lupus, and antiphospholipid antibody syndrome, were analyzed through
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multivariate analysis. 6 Post-pregnancy outcomes were later reassessed via clinic visits, telephone,
or mail. 6 Data obtained regarding gestational age fetal survival. 6
The frequency of abnormal pregnancy outcomes, identifiable laboratory findings, and
clinical factors that could predict adverse maternal and fetal outcomes among women diagnosed
with SLE, was the focus of the retrospective study performed by Liu et al., in 2010.1 The data of
111 women, 105 of whom were SLE parturients, between January 1990 and December 2008 were
reviewed. 1 The SLEDAI for the parturient was confirmed by senior rheumatologists. 1 The
laboratory assessments included: antinuclear antibodies, anti-double-stranded DNA antibodies,
lupus anticoagulant (LAC), anticardiolipin antibodies, and immunoreactive C3. 1 Additionally,
C4, serum creatinine, and 24-hour proteinuria were recorded before conception and were repeated
at first, second, and third trimester during pregnancy and within 2 months postpartum or
whenever a SLE flare-up were suspected.1
Definitions and Findings of Outcomes
Studies done by Abdwani et al. and Liu et al., define SLE using the 1997 America
College of Rheumatism classification.1,6 Additionally, both studies used the SLE Disease Activity
Index (SLEDAI) to define and assess the activity levels of the parturients disease. 1,6 Abdwani et
al. conducted a retrospective cohort study to determine the maternal and neonatal outcomes of
pregnancies in SLE patients. A sample of 147 pregnant women was involved in the study. 8 Out
of the 147 women, 56 (38%) had SLE, while 91(61.9%) were healthy. The healthy women were
included in the control group. 8 The Systemic Lupus Erythematosus Disease Activity Index
(SLEDAI) was used to assess the patients’ disease activity. 8 Pregnant women diagnosed with
SLE were treated with hydroxychloroquine, prednisolone, and azathioprine.8 Analyzing the data
helped the researchers identify that pregnant women with SLE had higher abortions (42.8% vs.
15.3%), gestational diabetes (28.3% vs. 10.2%), polyhydramnios (7.1% vs. 0.0%), previous
preterm pregnancies (8.9% vs. 1.0%), and Intrauterine growth retardation (21.4% vs. 0.0%) when
compared to women with normal health. 8 Additionally, pregnant women diagnosed with SLE
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were more likely to experience neonatal births that are preterm (28.5% vs. 1.0%; p < 0.001),
contain low birth weight (< 2 500 g) (32.1% vs. 1.0%; p < 0.001), and stillbirth (7.1% vs. 0.0%; p
= 0.010) than healthy women. 8 Based on the findings, SLE results in higher maternal and
neonatal complications. Thus, there is a need for pregnancies among women with SLE to be
accurately planned, monitored, and managed using the best practices provided by a
multidisciplinary team to decrease the occurrence of maternal and neonatal complications.22
Clowse et al. assessed the perils associated with increased lupus activity and the potential
complications in obstetric outcome. 6 In the study, the researchers use a national wide
representative sample to observe 277 pregnancies. 6 An analysis of the collected data helped the
researchers to identify that maternal mortality was 20-fold higher in women diagnosed with SLE
than those without the condition. 6 Clowse et al. identified that the peril of thrombosis,
transfusion, infection, and thrombocytopenia were three to seven-fold higher among women with
SLE. 6 Additionally, patients diagnosed with SLE had a higher peril for cesarean section (Odd
Ratio [OR]: 1.7), preterm labor (OR: 2.4), and pre-eclampsia (OR 3.0) compared to women
without SLE. Women with SLE were at a higher peril of thrombophilia, hypertension, and
diabetes, which are medical conditions that result in adverse pregnancy outcomes. 6 Clowse et al.
concluded that women with SLE are at increased peril for pregnancy and medical complications.6
Unlike Clowse et al., Kiran et al. focused on general anesthesia. 6, 23 The researchers
indicated that SLE's clinical symptoms among parturients vary with the severity of damage
impacted to organ systems such as renal, cardiac, musculoskeletal, respiratory, and neurological
systems. The researchers’ purpose was to assess the implications for practicing anesthesiologists
who provide care to parturients diagnosed with SLE, specifically those who need elective lower
segment cesarean section. In this case, the patient was admitted to the facility with hematuria and
vaginal bleeding. The patient was treated with 7 U of packed red cells and platelet-rich
concentrates. 23
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As an autoimmune disease, SLE is associated with complications such as increased fetal
loss, incidences of pre-eclampsia, and neonatal lupus. 21 The use of therapeutic interventions, such
as anticoagulants, steroids, and immunosuppressive, could risk anesthesia and surgery.21 Vyas et
al. study reported the perioperative activities and anesthetic management of a parturient with
SLE. The parturient had a bad obstetric history and underwent an elective caesarian section. 21
The patient had regular blood sugar, complete blood count, and urine examination. 21
Electrocardiography, liver, and renal function tests were conducted, which helped eliminate
systemic involvement. Low molecular weight heparin was administered to the patient twice a day
to improve fetal outcomes. The patient’s bleeding, clotting, and activated partial thromboplastin
time were monitored. Low molecular weight heparin was withheld 24 hours before the surgery. 21
The patient’s perioperative bleeding, clotting, and activated partial thromboplastin time were
normal. 21 The patient was administered 2 milliliters (ml) of 0.5% Bupivacaine in a lateral
position. 21 A 25G Quincke needle was used to achieve blockage at the T6 dermatome level. 21
Upon delivery, the baby cried after being born and had normal APGAR scores. 21 No signs of
neonatal lupus were identified. Vyas et al. concluded that administering 2 ml of 0.5%
Bupivacaine during spinal anesthesia, together with comprehensive monitoring, decreases the
occurrence of adverse outcomes. 21
Risk of Bias
One of the challenges of retrospective studies are the risks of bias and The Critical
Appraisal Skills Programme’s Checklists (CASP) provided the structural framework which
allowed the investigators to appraise the cohort studies and case control studies for bias.17
The retrospective nature of the study conducted by Liu et al. restricted researchers from assessing
how the adverse outcomes can be mitigated. 1 Additionally, the large cohort used by Nili et al, has
the potential to create a systematic error that maybe caused an over or under estimation of an
association.20
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Selection bias can occur in case-controlled studies if controls are more or less likely to be
exposed. The study by Vyas et al. provided no data analysis and is limited in nature given that the
report was of one patient.3 Bias can be avoided by carefully defining selection (inclusion) criteria.
Additionally, Have an adequately sized sample, as well as clear, homogenous definitions of
disease and exposure. Retrospective studies are self-limiting, however, if researchers select
precise and accurate measures of exposure and outcome in addition to sharing all data collected,
the risk of bias can be mitigated. The use of retrospective studies play a significant role in health
research, particularly when evidence from randomized controlled experiments is not available or
feasible.
DISCUSSION
Assessment of the Quality of the Included Studies
The investigators used RCTs in the systematic review to prevent selection bias leading to
improved quality of included studies.33 The selected studies involved equal distribution in a
selected population. The selected studies are suitable to establish the relations between an
intervention and outcome. The use of RCTs in the systematic review helps to promote the
generalizability of the study findings to different settings and populations. The selected studies
involve comprehensive abstracts containing information about all sections of studies, including
background, aim, discussion, results, and conclusion. The information presented in the article
helps in determining the strength of the study. An abstract help determine that the study is
consistent and contains generalizable results, suitable sample size, appropriate research design,
adequate control, and definitive conclusions. Among the selected studies, only a study by Vyas et
al. (2014) and Kiran et al. (2016) lacked a comprehensive abstract. Other studies, including that
of Abdwani et al. (2018), Clowse et al. (2005), Lui et al. (2012), Eudy et al. (2018), Nili et al.
(2013), and Liu et al. (2012), contained abstracts that have clearly presented information relating
to background, objective, method, study design, results, and conclusion.
Justification for the exclusion of studies
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The systematic review involved nine articles containing RCTs. The studies were
synthesized into two themes, including pregnancies complicated by SLE and parturient need for
cesarean section. Systematic Reviews and Meta-Analyses (PRISMA) checklist was used to locate
meta-analyses and systematic reviews for randomized studies.12 The electronic databases used in
the search process included MedLine (ProQuest), Cumulative Index to Nursing and Allied Health
Literature (CINAHL), and Excerpta Medica Database (EMBASE). The search results were
restricted to articles that were published in English from the year 2000 to 2020 to establish any
gaps within the literature. The search process involving CINAHL, Excerpta Medica Database
(EMBASE), and ProQuest yielded 3408 results. The investigators excluded 3111 articles for not
having substantial support for the proposed research. There were 150 articles excluded because
they were duplicates. The investigators assessed 123 full-text articles for eligibility. There were
eight relevant full-text articles that were selected by the investigators based on inclusion criteria.
The criteria were articles: Published between 2000 to present, written in the English language,
double-blinded RCTs, Systemic Lupus Erythematosus or SLE or Lupus, Cesarean Delivery or
Cesarean Section and Anesthesia, or Pregnancy or Obstetrics.
The exclusion of studies is justified because language is an important factor in the use
and dissemination of study findings.34 It was essential for the investigator to use a language that is
applicable to the target recipients of the study findings. The exclusion of articles to eradicate
duplicates was essential to facilitate accuracy in data collection, analysis, and production of
correct results. The exclusion helped to remove duplication of data to improve the validity and
reliability of study findings. The action of the investigators to exclude articles that did not contain
full text is justified to ensure that the selected sources have information relating to background,
objective, methodology, data analysis, results, and conclusion. The elimination of articles based
on the duration of publication is essential to ensure that the systematic review involves most of
the latest studies. Additionally, the use of double blinded RCTs helped in improving internal
validity.35
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Alternative Explanation for Observed Result
In a systematic review, data were collected from the selected studies. The investigators
analyzed collected data to generate results. In this part of the paper, a discussion of the results is
presented. Abdwani et al. (2018) conducted a study aimed to determine the maternal and neonatal
outcomes of pregnancies in SLE patients compared to pregnancies in healthy controls. The
researchers found out that pregnancies among patients with SLE were connected to abortions
(42.8% vs. 15.3%; p < 0.001), intrauterine growth retardation (21.4% vs. 0.0%; p < 0.001),
gestational diabetes (28.3% vs. 10.2%; p = 0.004), previous preterm pregnancies (8.9% vs. 1.0%;
p = 0.030), and polyhydramnios (7.1% vs. 0.0%; p = 0.020).8Findings of the a study by Abdwani
et al. (2018) relate to the results of a study by Eudy et al. (2018).8,13 The focus of Eudy et al.
(2018) was to determine reasons for medically, and cesarean indicated deliveries in a registry of
pregnant women with SLE compared to RA. The findings of the study indicated that SLE
pregnancies had discreetly higher rates of cesarean delivery (48% SLE vs. 30% RA), preterm
birth (24% SLE vs. 14% RA), and preeclampsia (15% SLE vs. 7% RA). The majority of preterm
births among women with SLE were indicated (70%), frequently for the health of the infant,
mother, or preeclampsia.8
Clowse et al. (2005) found out that high-activity lupus occurred in 57 pregnancies (21%).
There were fewer pregnancies among women with high activity lupus ended with live births
(77% versus 88% of those with low-activity lupus; P= 0.063). High-activity lupus in the first and
second trimesters caused a 3-fold increase in pregnancy loss. There were full-term deliveries in
15 pregnancies (26%) among women with high-activity lupus compared to 127 pregnancies
(61%) among those with no or mild lupus activity (P < 0.001). The results indicate that highactivity lupus is associated with negative obstetric Outcomes. The results relate to the findings of
Dietz (2019) that women with SLE compared with those without the condition have a higher rate
of miscarriage (18.7% vs. 16.8%), preterm birth (9.2% vs. 6.2%), and stillbirth (0.7% vs. 0.4%).31
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A study by Lui et al. (2012) showed similar results to those in Clowse et al. (2005) and
Dietz (2019). Lui et al. (2012) found out that there were 23 elective, two spontaneous, and five
stillbirths among women with SLE. There were only 17% live births in 81 of the pregnancies
among patients with SLE. The findings of the study reveal that there is a high rate of stillbirths
among women with SLE. Nili et al. (2013) also discovered that SLE is associated with increased
negative obstetric outcomes. SLE increased the risks of Caesarean section (OR 1.8; 95% CI 1.1 to
2.8, P = 0.005), need for blood transfusion (OR 6.9; 95% CI 2.7 to 17, P = 0.001), postpartum
hemorrhage (OR 2.4; 95% CI 1.3 to 4.3, P = 0.003), postpartum fever (OR 3.2; 95% CI 1.7 to 6.1,
P = 0.032), gestational age ≤ 37 weeks (OR 2.1; 95% CI 1.3 to 3.4, P = 0.001), and small for
gestational age babies (OR 1.7; 95% CI 1.005 to 2.9, P = 0.047). The findings support the
outcomes of a study by Pastore et al. (2019) that found out that woman with systemic lupus
erythematosus (SLE) is associated with preterm premature rupture of membranes (16.6%),
preterm labor (12.7%), and preeclampsia or eclampsia (15.6%).
Kiran et al. (2016) found that anesthetic management for cesarean section among patients SLE
facilitated recovery and prevented complications. The patient’s vitals were stable with no damage
to the organ systems such as the hematological, neurological, cardiac, musculoskeletal, renal, and
respiratory systems were identified.23 The findings support the results of a study by Vyas et al.
(2014), who found out that successful management of an antinuclear antibody among women
with SLE was associated with positive obstetric outcomes. The patient had normal clotting,
bleeding, and activated partial thromboplastin time. The baby cried immediately after delivery; no
signs of neonatal lupus were identified and had a normal APGAR score.3
Gaps in Research
There is a gap in research relating to the studies included in the systematic review. The
studies have not explored the approach of dealing with pregnancies among mothers with SLE.37,
38, 39, 40

It is essential for investigators to investigate suitable interventions for preventing adverse
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effects associated with SLE. Additionally, it is necessary to investigate suitable interventions for
improving obstetrical outcomes among mothers with SLE.
Limitations of the Systematic Review
The first limitation of the study relates to the inclusion of articles that are only written in
English that can result in language bias. The bias might negatively affect the conclusion of the
systematic review. Language bias can also exclude people from using the finding of the study.
The second limitation in this systematic review is dissimilarities among the eight included RCTs.
The investigators in the included RCTs have a different definition of SLE. For instance, Nili et al.
(2013) define SLE as a chronic multisystem inflammatory autoimmune condition characterized
by autoantibody production with a wide range of manifestations and multiple body systems.20
Abdwani et al. (2018) define SLE as a chronic autoimmune condition that affects women mainly
of childbearing age. The dissimilarity may have a negative effect on the reliability of the study
findings. Additionally, there is a high heterogeneity among the selected studies with different
investigators' different definitions of dependent variables. Among dependent variables contained
in the selected studies are obstetrical outcomes, maternal and fetal outcomes, and pregnancy
outcomes.20, 24, 29
The third limitation of the systematic review is differences in the time intervals for data
collection among the selected studies. Liu et al. (2012) collected data involving SLE patients
from January 1990 to December 2008. Clowse et al. (2005) collected data of patients from 1987
to 2002. Nili et al. (2013) used data collected between January 1, 1988, and December 31, 2008.
Mehta et al. (2019) retrieved data collected from 1998 through 2015. Abdwani et al. (2018) used
data of neonates born to mothers with SLE from 2007 to 2013. Heterogeneity among included
studies may negatively affect the reliability of this systematic review. Another limitation is that
most of the studies included in the systematic review involved small sample sizes. For instance,
Liu et al. (2012) involved 105 SLE patients, Clowse et al. (2005) involved 267 pregnancies, while
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Nili et al. (2013) focused on 97 pregnancies among women with SLE.1, 20, 29 The use of a small
sample size reduces reliability and validity of study findings.41
Recommendations for Future Research
To reduce and prevent adverse outcomes for babies are related to prematurity among
mothers with SLE, it is essential to develop a suitable intervention involving a multidisciplinary
approach. A multidisciplinary method is suitable to facilitate diagnosis and successful
management of SLE among pregnant women to deal with complications during childbirth.
Further research should focus on including homogenous studies making measurement outcomes
comparable to other published studies, thus reducing heterogeneity. The investigators should use
many RCTs containing larger sample sizes and involving multi-centers to facilitate the
generalizability of findings. Future RCTs should include interventions suitable in reducing or
eliminate adverse fetal outcomes, including preterm birth, fetal loss, and children with congenital
heart block. The further study should focus on RCTs dealing with intervention dealing with highrisk pregnancies in women with SLE. Additionally, the selected studies in the further research
should involve the implementation of educational interventions targeting women with SLE to
ensure that their pregnancies are accurately planned, managed, and monitored to prevent adverse
effects.
CONCLUSION OF LITERATURE REVIEW
The selected studies have definitive conclusions that facilitate generalizability.35 Based
on conclusions of the studies, lupus in pregnancy is associated with adverse fetal outcome
including preterm birth, fetal loss, and reduced live births.1, 6 The conclusions from the selected
studies helps to generalize that mothers with SLE have a high risk of medically indicated
delivery, cesarean section, blood transfusion, and postpartum hemorrhage.20 The investigators can
generalize the findings based on the conclusion that mothers with SLE have a higher chance of
delivering smaller babies, premature babies, and children with congenital heart block.7, 20 The
conclusions of the selected studies are essential in generalizing the findings indicating that it is
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essential to closely monitor and treat pregnancies in lupus patients to improve outcomes.1
Pregnancy among women with SLE should be accurately monitored, planned, and managed using
a multidisciplinary treatment schedule.8
Overall, with the advancements in healthcare, providers now have a better understanding
of the maternal- foetal dyad that can present during the management of the lupus mother during
cesarian section. The literatures reviewed highlighted that in the presence of highly active lupus;
there may be an increase in premature birth and a decrease in live births. Additionally,
pregnancies in lupus patients must be closely observed and treated during all trimesters to
improve pregnancy outcomes. Providers are more likely to encounter an increase in pregnant
lupus patients and must understand the multisystem nature of the disease, the potential for severe
organ involvement, and the drugs that are used in treatment. The outcome of pregnancies can be
successful in most women with SLE, however there can be increase in SLE activity, even in
patients with the disease who are well controlled. Having a well-formalized anesthesia care plan,
for parturients presenting for cesarean sections can help to limit negative outcome and optimize
care.
QUALITY IMPROVEMENT IMPLEMENTATION PLAN
Setting
The setting for this project took place in Fort Lauderdale, Florida. In 2019 and 2020, the
estimated population Broward county was 1,952,778 and 1,944,375 respectively.42 The Broward
community hospital used for this project is a 716 -bed facility which has a team of 3,100 medical
professionals and approximately 800 physicians.43 Anesthesia services are provided by Anesco
Broward North Anesthesia Group, LLC (Anesco); they provide anesthesia services for five
hospitals in the district.
Recruitment
The target population was recruited after obtaining approval from the investigators at
Florida International University (FIU) and Anesco. The International Review Board (IRB)
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deemed the project exempt through the Exempt Review process. The population of interest was
certified registered nurse anesthetists (CRNAs) and anesthesiologists. Anesco identified the
participants and provided an email contact list, which was utilized to connect with the participants
virtually.
Project Participants
Anesco staff CRNAs and anesthesiologists were eligible to participate in the educational
intervention. Student Registered Nurse Anesthetists (SRNAs) and anesthesia medical residents
were excluded from participation in the project. Anesco staff that met inclusion criteria were
emailed and provided the voluntary pre-test survey, the educational voice-over PowerPoint, and
the post-test survey to complete (See Appendix E and F). A total of 28 participants were
contacted, and six participants completed the pre-test and post-test.
Intervention
An evidence-based education module addresses the anesthetic management of the SLE
parturient during cesarean section. The presentation identifies that anesthesia providers must have
a thorough understanding of the clinical implications of SLE, during the obstetric management
for a cesarean section, as this will reduce morbidity and mortality for mother and newborn. The
intervention was staged, with the pretest survey provided first to analyze the current knowledge
of the SLE parturient and their anesthetic management during cesarean section. Upon pre-test
completion, participants were provided with an evidence-based voiceover PowerPoint
presentation. The education module provided staff with defining presentation and complications
associated with SLE; it identified the importance of an individualized anesthetic care plan for
presenting parturient, identified the multisystemic presentation of the high risk parturient, and
discussed the results of seven studies used in the literature review that was used to guide this
project. Lastly, subjects completed a post-test survey to determine learning outcomes, the efficacy
of the intervention, and overall interest in having an anesthetic management plan for the SLE
parturient during cesarean section.
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Procedure
Participants on the email list provided by Anesco were sent an informational email
inviting them to participate in the project. Within the content of the email, there was an
anonymous link provided, which gave subjects access to the pre-test questionnaire through the
Qualtrics survey platform. After completing the survey, participants were able to access the 15minute voiceover PowerPoint presentation via email. Upon completing the educational
intervention, the Qualtrics survey platform was accessed by an anonymous link that directed users
to the post-test survey. Participant privacy was never jeopardized as no personal identifiable
information was required to partake in this project.
Protection of Human Subjects
IRB approval was obtained before any of the activities involved in this project were
initiated. The IRB has deemed this project exempt under the Exempt Review process as it fits one
of the exempt category descriptions defined by the Federal Regulations for Protection of Human
Research Subjects.34 There is no more than “minimal risk” to human subjects, and the
identification of human subjects cannot be readily determined directly or through identifiers
associated with the subjects.44 Additionally, this research project's pre-test and post-test survey
responses do not place the subjects at risk for any civil or criminal liability.44 Participation will
not result in damaging consequences that would affect the subjects financially, their employment
or education status, or reputation.44
Analysis
The primary tools utilized in the study included a preassessment and post-assessment
application used to analyze the effects of the educational module. The Qualtrics platform was
used to generate both tests and the educational voiceover PowerPoint presentation. Ten questions
in the pre-test survey were used to determine baseline knowledge of SLE and the management of
parturients during cesarean sections. In contrast, the post-assessment survey included the same
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questions to validate the effectiveness of the educational PowerPoint and the application of
knowledge. All data is confidential, and no subject identifiers were recorded in the study.
Measure
The primary DNP student obtained Anesco associates’ email addresses. The emails were
used to communicate the study's purpose, intent and to send the pretest, posttest, and voicer
PowerPoint presentation. Each question was measured via Qualtrics statistical analysis to
identify base knowledge before and after participation in the study. Through analysis, the impact
of the educational module will be assessed based on participation outcomes and patterns
identified. All data will be stored in a password-protected computer by the co-investigator.
IMPLEMENTATION RESULTS
Pre/Post-Test Demographics
The pre-test demographics are represented below in Table 4.
Table 4. Pre/Post-Test Participant Demographics
Demographics
N (%)
Total Participants

6 (100%)

Gender
Male

2 (33.3%)

Female

4 (66.7%)

Age
25 -Ge
35 yr.

4 (66.7%)

36 - 45 yr.

1 (16.7%)

46 – 55 yr.

1 (16.7%)

55 – 66 yr.

0 (0%)

Ethnicity
Hispanic

1 (16.7%)

Caucasian

4 (66.7%)

African American

1 (16.7%)

Asian

0 (0%)

Other

0 (0%)

Education
Masters

4 (66.7%)
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Doctorate

2 (33.3%)

Years of Practice
0 – 2 yr.

2 (33.3%)

2 – 5 yr.

2 (33.3%)

5 – 10 yr.

1 (16.7%)

10 – 20 yr.

1 (16.7%)

A total of six participants completed the study in its entirety. The pre-test demographics
representation included female (n=4, 66.7%) to male participants (n=2, 33.3%). Various
ethnicities were also represented among the participants, with the majority being Caucasian (n=4,
66.7%), followed by African American (n=1, 16.7%), and Hispanics (n=1, 16.7%). Most
participants fell into the 25 to 35 age group (n=4, 66.7%), while the 36 to 45 age group accounted
for (n=1, 16.7%). One of the surveyed respondents fell into the 46 to 55 category (n=1, 16.7%)
and none in the 55 to 66 age range. Two participants were CRNAs with Doctoral degrees (n=2,
33.3%) and the remaining participants were graduates with a Master’s degree (n=4, 66.7%).
Lastly, all individuals were asked how many years they have been practicing as CRNAs: 0 to 2
years (n=2, 33.3%), 2 to 5 years (n=2, 33.3%), 5 to 10 years (n=1, 16.7%), and 10-20 years (n=1,
16.7%).
Pre-Test Identification of Knowledge of Anesthetic Management of the Systemic Lupus
Erythematosus Parturient During Cesarean Section

The pre-test consisted of 10 questions that assessed current knowledge of anesthetic
management of the systemic lupus erythematosus parturient during cesarean section. All the
participants were able to define SLE (n=6, 100%). None of the participants correctly identified
some of challenges faced by parturients with SLE or the number of Americans who struggle with
the disorder (n=0, 0%). All but two participants identified that women of childbearing age were
primarily affected by SLE (n=4, 66.7%). All participants identified that a successful anesthetic
management plan for the SLE parturient must be individually tailored (n=6, 100%).
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The pulmonary involvement in the SLE parturient were all correctly identified by all the
participants completing the pre-test (n=6, 100%). When asked to identify what the studies used in
the systemic review concluded, only 2 participants successfully identified that SLE parturients
had a higher risk of medically directed deliveries and cesarean sections (n=2, 33.3%). One of the
final two pre-test questions focused on the prolonged use of glucocorticoids which are used for
immunosuppression. Only one respondent identified that its use would increase the risk of
atlantoaxial subluxation (n=1, 16.7%). Optimizing flow and maintaining normal sinus rhythm
were identified by 4 respondents as the correct cardiovascular management of the parturient with
SLE during a cesarean section (n=4, 66.7%). Finally, all participants agreed with the successful
use of regional anesthesia in the parturient undergoing cesarean section, with SLE (n=6, 100%).
Post-Test Identification of Knowledge of Anesthetic Management of the Systemic Lupus
Erythematosus Parturient During Cesarean Section
Table 5 highlights the pre-test and post-test differences in responses.
Table 5. Difference in Pre- and Post-Test Knowledge
Questions
1. Systemic lupus erythematosus is defined as:
2. Some of the challenges faced by the parturient with
Systemic lupus erythematosus include:
3. Approximately how many Americans struggle with
systemic lupus erythematosus?
4. Systemic lupus erythematosus primarily affect:
5. Successful anesthetic management of the systemic lupus
erythematosus parturient, during a cesarean section relies
heavily on:
6. Pulmonary involvement in a systemic lupus
erythematosus parturient include:
7. The studies used in this systematic review concluded that
systemic lupus erythematosus parturients:
8. What can prolong use of glucocorticoids for
immunosuppression lead to in a parturient with Systemic
lupus erythematosus:
9. The principal goal of cardiovascular management in the
Systemic lupus erythematosus parturient:
10. Epidural anesthesia for cesarean delivery in the
Systemic lupus erythematosus parturient:
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Pretest
100%
0%

Posttest
Difference
100%
0%
66.7%
66.7%

0%

50%

50%

66.7%
100%

100%
100%

33.3%
0%

100%

100%

0%

33.3%

100%

66.7%

16.7% 66.7%

33.3%

66.7%

100%

33.3%

100%

100%

0%

After participants viewed the voiceover PowerPoint presentation, most of the categories
increased from baseline knowledge. The most significant increase in knowledge improvement
were seen in participants being able to identify the challenges faced by parturients with SLE and
the ability to identify what the studies used in the systemic review concluded about the
management of the SLE parturient; the questions reflected a 66.7% increase. There was an
increase of 50% in knowledge pertaining to the identification of number of Americans who
struggle with SLE.
After watching the educational presentation, all participants were able to correctly
identify the pulmonary involvements in SLE (n=6, 100%. The educational intervention also
resulted in a 100% response (n=6, 100%) in the successful use of regional anesthesia, unless
contraindicated in the SLE parturient. An understanding of the principal goal of the
cardiovascular management in the SLE patient reflected a 33.3% increase in the respondents’
knowledge, after the educational intervention. Additionally, the same percentile increase was
noted in participants being able to identify the principal goals of the cardiovascular management
in the SLE parturient (n=2, 33.3%).
Summary of Data
Overall, most of the pre-test and post- test responses, demonstrated an increase in
knowledge base of the participants. Notable knowledge improvements were seen in the
participating anesthesia providers’ ability to identify some of the challenges faced by the
parturient with SLE and identifying the amount of Americans who struggle with the disorder.
Additionally, anesthesia providers who participated in the study showed an improvement in their
knowledge deficit regarding the systemic studies used in the presentation. The providers who
participated were able identify that a higher risk of medically directed deliveries and cesarean
section were seen in parturients who presented with SLE. Seven out of 10 post test questions
resulted in the correct answer, after viewing the educational presentation.
Graph 1 below shows individual results.
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Graph 1. Individual Results of Participants

Individual Results of Participants
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IMPLEMENTATION DISCUSSION
Limitations
Several limitations are identified in this study, including a small sample size and the
length of time required for participants to complete the study. Out of the 36 emails sent to
anesthesia providers from Anesco North Broward Anesthesia Group, only six participants
completed the pre-test and post-test survey. A larger and more diverse sample size would have
reflected a more accurate representation of the knowledge of anesthetic management of the SLE
parturient during a cesarean section. Additionally, the email recipients were all CRNAs and
excluded anesthesiologists. Lastly, participants were given a limited time of 2 weeks to complete
the project, and an extended time frame may have increased the response rate.
Future Implications for Advanced Practice Nursing
For many years pregnancy has been contraindicated in patients with SLE, particularly
when multisystem involvement was present. Today, pregnancy is no longer considered
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impossible in women with lupus. Yet, lupus pregnancies are still considered high-risk. The
prognosis has considerably improved for pregnant women but the fetal risk, although
progressively reduced, is still higher in pregnancies of patients with SLE than in pregnancies of
healthy women. Miscarriage, premature delivery, and preeclampsia, as well as heart problems in
the baby are the major complications that can occur. Anesthesia providers’ knowledge of SLE
and management of parturients during a cesarean section has increased through educational
intervention. The principal goal of the management of a parturient with SLE.
Future studies may benefit from understanding anesthesiologists’ views and attitudes
towards future studies may benefit from the adverse fetal outcome including fetal loss, preterm
birth, and SGA increases significantly with SLE flares during pregnancy with
preeclampsia/eclampsia, thrombocytopenia, and active SLE serving independent predictors of
adverse fetal and maternal outcome. In general, lupus in pregnant population is generally similar
to other cohorts. Pregnancies can be successful in most women with SLE. However, an increase
in SLE activity can occur in a significant number of patients, even those who are well controlled,
as demonstrated by the studies reviewed.
CONCLUSION
Evidence shows that parturients with SLE present with a higher incidence of systemic
complications that increases the risk of poorer outcome for both the mother and baby. Anesthesia
providers must have a thorough understanding of the clinical implications of SLE, during the
obstetric management for a cesarean section, as this will reduce morbidity and mortality for
mother and newborn. Systemic Lupus Erythematosus has several disease manifestations that may
be exhibited in the parturient during cesarean delivery. The advancements in healthcare, providers
now have a better understanding of the maternal- foetal dyad that can present during the
management of the lupus mother during cesarian section. The literatures reviewed highlighted
that in the presence of highly active lupus; there may be an increase in premature birth and a
decrease in live births. Additionally, pregnancies in lupus patients must be closely observed and
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treated during all trimesters to improve pregnancy outcomes. Providers are more likely to
encounter an increase in pregnant lupus patients and must understand the multisystem nature of
the disease, the potential for severe organ involvement, and the drugs that are used in treatment.
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Appendix
Appendix A: PRISMA Flow Diagram
Figure 1. PRISMA Flow Diagram

Records identified through
Cumulative Index to Nursing and
Allied Health Literature (CINAHL),
MedLine (ProQuest) and Excerpta
Medica Database (EMBASE)
(n= 3408)

(n = 217)
Records excluded for not having substantial
support for the proposed research
(n=3111)

Duplicates
(n=150)

(n = 80)

Full- text articles assessed
for eligibility
(n=123)

Full-text articles excluded, with
reasons
(n = 16)
Non-SLE parturients (3)
Parturients with SLE, with
terminated pregnancies (2)
Systematic reviews of literature (5)
Outcome not appropriately reported
(6)

Studies included in
qualitative synthesis
(n =8)
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Appendix B: Literature Matrix Table

Table 3. Studies Included in the Appraisal
Author (Year)
& Type of
Study

Study Method, Participants,
Interventions, & Setting

Findings

Abdwani et al.
(2018)

Maternal and neonatal outcomes
of pregnancies in SLE patients.

Abortions (42.8% vs. 15.3%; p <
0.001),
Gestational diabetes (28.3% vs. 10.2%;
p = 0.004).
Polyhydramnios (7.1% vs. 0.0%; p =
0.020),
Previous preterm pregnancies (8.9%
vs. 1.0%; p = 0.030),
Intrauterine growth retardation (21.4%
vs. 0.0%; p < 0.001).

Pregnancies in health controls
were used as the comparison.
Retrospective
Cohort Study

The study was conducted in a
tertiary hospital in Oman
147 pregnancies
56 (38%) parturients with SLE
were involved in the study.
91(61.9%) parturients without
SLE

Eudy et al.
(2018)

Retrospective
Cohort Study

Parturients with SLE and RA
prospectively followed until childbirth to assess type of birth and
gestational age of infant at time of
birth.
The study was conducted in a
tertiary hospital in the United
States
126 total pregnancies
82 parturients with SLE were
involved in the study.
44 parturients with RA
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S LE pregnancies had modestly higher
rates of preterm birth (24% SLE vs
14% RA),
pre-eclampsia (15% SLE vs 7% RA)
cesarean delivery (48% SLE vs 30%
RA)
Majority of preterm births among
women with SLE were indicated
(70%), commonly for pre-eclampsia or
the health of the infant or mother.

Clowse et al.
(2005)

Retrospective
Cohort Study

Lui et al. (2012)

Retrospective
Cohort Study

Mehta, et al.
(2019)

Retrospective
Cohort Study

229 (85.8%) resulted in a live birth.
High-activity lupus occurred in 57
pregnancies (21%).
Fewer pregnancies among women with
high activity lupus ended with live
births (77% versus 88% of those with
low-activity lupus; P= 0.063).
Study was conducted in the United Full-term delivery was achieved in 15
pregnancies (26%) among women with
States.
high-activity lupus.
267 pregnancies in 203 parturients 127 pregnancies (61%) achieving fullterm in those with no or mild lupus
with SLE were evaluated in this
activity (P < 0.001).
study.
High-activity lupus in the first and
second trimesters led to a 3-fold
increase in pregnancy loss
(miscarriages and perinatal mortality).
Frequency of abnormal pregnancy There were 23, 2, and 5 elective,
spontaneous, and still births,
outcomes, Identifiable laboratory
respectively.
findings and clinical factors that
Live births were reported in 81 of the
could predict adverse maternal and
pregnancies out of which 17% were in
fetal outcomes among women
the patients with SLE.
diagnosed with SLE
Preeclampsia/eclampsia (OR ¼ 14.83,
95% CI: 3.83–57.41) and
The study was conducted in China. thrombocytopenia (OR ¼ 4.43, 95%
CI: 1.12–17.60) were predictors of
111 Parturients
fetal loss; preeclampsia/eclampsia (OR
¼ 8.04, 95% CI: 2.00–32.34).
105 parturients with SLE were
Preterm birth; preeclampsia/eclampsia
involved in the study.
(OR ¼ 8.92, 95% CI: 2.25–35.44)
were significantly associated with
active SLE (OR ¼ 19.90, 95% CI:
2.38–166.27). Thrombocytopenia (OR
¼ 4.03, 95% CI: 1.24–17.25) were
significant predictors of maternal SLE
flare-up.
Assess all pregnancies in a cohort
of lupus patients who were
observed prospectively from 1987
to 2002.

Assess nationwide trends and
disparities in maternal and fetal
complications among pregnant
women with SLE
Adult pregnant women with and
without SLE who had
hospitalizations recorded in the
National Inpatient Sample (NIS)
database between 1998- 2015
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Outcomes improved during those 18
years.
In-hospital maternal deaths (per
100 000 admissions) declined among
patients with as well as those without
SLE (442 vs. 13 for 1998 to 2000 and
<50 vs. 10 for 2013 to 2015),
Decrease was greater in women
with SLE (difference in trends, P <
0.002).

Study occurred in United States.
93 820 parturients with SLE were
involved in the study

The percentage of patients with SLE in
all pregnancy-related, as well as
delivery-related, admissions increased
significantly.

78 045 054 parturients without
SLE
Vyas et al.
(2014)

Management of an antinuclear
antibody positive parturient who
spinal anesthesia was administered
during caesarian section

Case- Control
Study

No data analysis conducted
A report of the guidelines adhered
during the spinal anesthesia

Nili et al. (2013)

Retrospective
Cohort Study

Determine maternal and neonatal
outcomes in pregnancies
complicated by systemic lupus
erythematosus (SLE).
Study occurred in Canada.
97 parturients with SLE
211255 parturients without SLE
The study was conducted at an
intensive care unit and department
of anesthesiology of a healthcare
facility.

Kiran et al.
(2016)

Anesthetic management of a
parturient with who underwent
elective lower segment cesarean
section

Case- Control
Study

No measurement of data reported
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It was identified that the patient had a
normal bleeding, clotting, and
activated partial thromboplastin time.
The baby cried immediately after
delivery, had a normal APGAR score,
and no signs of neonatal lupus were
identified.

SLE increased the risks of Caesarean
section (OR 1.8; 95% CI 1.1 to 2.8, P
= 0.005), postpartum hemorrhage (OR
2.4; 95% CI 1.3 to 4.3, P = 0.003),
need for blood transfusion (OR 6.9;
95% CI 2.7 to 17, P = 0.001),
postpartum fever (OR 3.2; 95% CI 1.7
to 6.1, P = 0.032), small for gestational
age babies (OR 1.7; 95% CI 1.005 to
2.9, P = 0.047), and gestational age ≤
37 weeks (OR 2.1; 95% CI 1.3 to 3.4,
P = 0.001).
Neonatal death was not shown to be
more common in women with SLE
(RR 3.05; CI 0.43 to 21.44, P = 0.28).
patient’s recovery from general
anesthesia was not associated with any
complications. The patient’s vitals
were stable and no damage to the
organ systems such as the
neurological, musculoskeletal, cardiac,
renal, hematological, and respiratory
systems were identified.

Appendix C: IRB Exception Letter

Page 53 of 63

Appendix D: Project Consent Form

ADULT CONSENT TO PARTICIPATE IN A RESEARCH STUDY
Improving Provider Knowledge on the Anesthetic Management of the Parturient with Systemic
Lupus Erythematosus During a Cesarean Section: A Quality Improvement Project
SUMMARY INFORMATION
Things you should know about this study:
•
•

•
•
•
•
•

Purpose: The purpose of the study is to improve provider knowledge on the anesthetic
management of the parturient with systemic lupus erythematosus (SLE) during a
cesarean section
Procedures: If you choose to participate, you will be asked to complete a pre-test.
After the completion of the pre-test, participants will then attend the classroom style
educational session, which is expected to last approximately 20-30 minutes. Four
weeks after completing the educational session, participants will be asked to complete
the post-test.
Duration: This will take about 1hour and 10 minutes.
Risks: Participants are not expected to experience any risks, harms, or discomforts
though participation in this project.
Benefits: The main benefit to benefits to participants include improved knowledge of
the pregnancy variances of patients with SLE and the anesthetic management for this
population during a cesarean section.
Alternatives: There are no known alternatives available to you other than not taking
part in this study.
Participation: Taking part in this research project is voluntary.

Please carefully read the entire document before agreeing to participate.

PURPOSE OF THE STUDY
The primary objective of this project is to improve the anesthetic healthcare provider
knowledge of the pregnancy complications associated with Systemic Lupus Erythematous (SLE).
The scholarly aim of this study to provide anesthesia providers with an understanding of the
multisystemic complications that can arise with the SLE parturient and the effects that they can
have on perioperative management during a cesarean section. Upon the completion, participants
should have a sound understanding of the disorder and be able to develop an individualized
anesthetic care plan that is intended for successful perioperative management of the SLE
parturient.
NUMBER OF STUDY PARTICIPANTS
If you decide to be in this study, you will be one of 20 people in this research study.
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DURATION OF THE STUDY
Participation is expected to span a total of approximately 2 months. The pre-test and post- test
assessment are expected to take approximately 15-20 minutes each to complete. The educational
session is expected to last approximately 20-30 minutes.
PROCEDURES
If you agree to be in the study, we will ask you to do the following things:
1. Complete a 10-question pre-test.
2. Review a 20–30-minute educational presentation on the management of the parturient with
systemic lupus erythematosus during a cesarean section
3. Complete a 10-question post-test.
RISKS AND/OR DISCOMFORTS
The study has the following possible risks to you: Participants are not expected to experience any
risks, harms, or discomforts though participation in this project.
BENEFITS
The study has the following possible benefits to you: This study will benefit society by guiding
anesthesia health care providers in the successful perioperative management of the SLE parturient
during a cesarean delivery.
ALTERNATIVES
There are no known alternatives available to you other than not taking part in this study. Any
significant new findings developed during the course of the research which may relate to your
willingness to continue participation will be provided to you.
CONFIDENTIALITY
The records of this study will be kept private and will be protected to the fullest extent provided
by law. In any sort of report, we might publish, we will not include any information that will
make it possible to identify you. Research records will be stored securely, and only the researcher
team will have access to the records. However, your records may be inspected by authorized
University or other agents who will also keep the information confidential.
USE OF YOUR INFORMATION
No identifiable private information is to be collected. Demographic data, including gender, age,
ethnicity, and title will be obtained as part of the survey.
COMPENSATION & COSTS
There are no costs to you for participating in this study.
RIGHT TO DECLINE OR WITHDRAW
Your participation in this study is voluntary. You are free to participate in the study or withdraw
your consent at any time during the study. You will not lose any benefits if you decide not to
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participate or if you quit the study early. The investigator reserves the right to remove you
without your consent at such time that he/she feels it is in the best interest.
RESEARCHER CONTACT INFORMATION
If you have any questions about the purpose, procedures, or any other issues relating to this
research study you may contact Alicia M. Bennett a, (954) 842-9778 or abenn046@fiu.edu.
IRB CONTACT INFORMATION
If you would like to talk with someone about your rights of being a subject in this research study
or about ethical issues with this research study, you may contact the FIU Office of Research
Integrity by phone at 305-348-2494 or by email at ori@fiu.edu.
PARTICIPANT AGREEMENT
I have read the information in this consent form and agree to participate in this study. I have had
a chance to ask any questions I have about this study, and they have been answered for me. I
understand that I will be given a copy of this form for my records.

________________________________
Signature of Participant

__________________
Date

________________________________
Printed Name of Participant
________________________________
Signature of Person Obtaining Consent

__________________
Date
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Appendix E: Pretest/ Post Test Survey Questions
INTRODUCTION
The primary objective of this project is to improve the anesthetic healthcare provider knowledge
of the pregnancy complications associated with Systemic Lupus Erythematous (SLE). The
scholarly aim is to provide anesthesia providers with an understanding of the multisystemic
complications that can arise with the SLE parturient and the effects that they can have on
perioperative management during a cesarean section.
Please answer the question below to the best of your ability. The questions are presented in a
multiple-choice format and are meant to measure knowledge and perceptions on the anesthetic
management of the parturient with SLE, during a cesarean section.
PERSONAL INFORMATION
1. Gender: Male Female

Other________

2. Age: ______
3. Ethnicity: Hispanic Caucasian African American/ Black Asian
Other_________
4. Position/Title: _________________________________
5. Level of Education: Associates

Bachelors

Masters

Other ___________
6. How many years have you been an anesthesia provide?
Over 10

5-10 years

2-5 years
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1-2 year

QUESTIONNAIRE
1. Systemic lupus erythematosus is defined as:
a. An autoimmune disorder that only targets the respiratory system
b. A multisystem autoimmune disorder
c. A disorder that only targets the pulmonary and cardiovascular system
d. A disorder that does not affect any organ system
2. Some of the challenges faced by the parturient with Systemic lupus erythematosus
include:
a. Lupus flares
b. Venous thromboembolism
c. Pre-eclampsia
d. All of the above
3. Approximately how many Americans struggle with systemic lupus erythematosus?
a. 50,000
b. 10,000
c. 1 million
d. 200,000
4. Systemic lupus erythematosus primarily affect:
a. Women older than 75 years
b. Women of childbearing age
c. Children less than 5 years of age
d. Men younger than 25 years

5. Successful anesthetic management of the systemic lupus erythematosus parturient, during
a cesarean section relies heavily on:

a. The gestational age of the baby
b. the use of the same anesthetic plan, regardless of patient presentation
c. An anesthetic plan that is individually tailored
d. The length of the procedure
6. Pulmonary involvement in a systemic lupus erythematosus parturient include:
a. Pulmonary hypertension
b. Pleural effusion
c. Alveolar hemorrhage
d. All of the above
7. The studies used in this systematic review concluded that systemic lupus erythematosus
parturients:
a. Have higher risk for intraoperative and post-operative blood transfusions
b. Have infants with increased morbidity and mortality
c. Have a higher risk of medically directed deliveries and cesarean section
d. All of the above
8. What can prolong use of glucocorticoids for immunosuppression lead to in a parturient
with Systemic lupus erythematosus:
a. headaches
b. osteoporosis
c. increased risk of atlantoaxial subluxation
d. B & C
9. The principal goal of cardiovascular management in the Systemic lupus erythematosus
parturient:
a. Is to keep blood pressure low, for optimal management.
b. Is to optimize flow, and maintain a normal sinus rhythm.
c. Allows for high pulmonary vascular resistance (PVR).
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d. Ensures that systemic vascular resistance is significantly reduced.
10. Epidural anesthesia for cesarean delivery in the Systemic lupus erythematosus parturient:
a. Can results in sympathetic blockade
b. Has no effect in the parturient
c. Is never a safe option for the parturient
d. Is always a safe option during a cesarean delivery
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Appendix F: DNP Project Educational Module PowerPoint Presentation
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